A drug-loaded nanocomposite fiber membrane system and its preparation method and application

A composite fiber membrane and drug-loaded nanotechnology, which is applied in the field of fiber membranes, can solve the problems of prolonging drug release time, unable to achieve multi-stage drug release, etc., and achieve the effect of long-term drug release and drug efficacy.

Active Publication Date: 2022-05-03
SHENZHEN GUANGYUAN BIOMATERIAL CO LTD
View PDF12 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] However, several nanofibrous membranes involved in the above patents can only prolong the drug release time to a certain extent, and cannot achieve effective and controllable multi-stage drug release.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A drug-loaded nanocomposite fiber membrane system and its preparation method and application
  • A drug-loaded nanocomposite fiber membrane system and its preparation method and application
  • A drug-loaded nanocomposite fiber membrane system and its preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0072] This embodiment provides a drug-loaded nanocomposite fiber membrane system, the drug-loaded nanocomposite fiber membrane system includes a first nanofiber layer, a second nanofiber layer and a third nanofiber layer;

[0073] The first nanofibrous layer includes poly(lactic-co-glycolic acid) (PLGA) (molecular weight is 60000), polydioxanone (PDO) (intrinsic viscosity is 1.2-2.4dL / g) and paclitaxel, PLGA and The mass ratio of PDO is 9:1, paclitaxel accounts for 15% of the total mass of PLGA and PDO, and the molar ratio of LA structural unit and GA structural unit in PLGA is 1:1;

[0074]The second nanofibrous layer includes polylactic acid-glycolic acid copolymer (PLGA) (molecular weight is 80000), polyglycolic acid (PGA) (intrinsic viscosity is 0.5-1.8dL / g) and paclitaxel, and the mass ratio of PLGA to PGA is is 93:7, paclitaxel accounts for 10% of the total mass of PLGA and PGA, and the molar ratio of LA structural unit to GA structural unit in PLGA is 3:1;

[0075] Th...

Embodiment 2

[0082] This embodiment provides a drug-loaded nanocomposite fiber membrane system, the drug-loaded nanocomposite fiber membrane system includes a first nanofiber layer, a second nanofiber layer and a third nanofiber layer;

[0083] The first nanofibrous layer comprises poly(lactic-co-glycolic acid) (PLGA) (molecular weight is 120000), polydioxanone (PDO) (intrinsic viscosity is 2.4-4.8dL / g) and doxorubicin, The mass ratio of PLGA to PDO is 8:2, doxorubicin accounts for 15% of the total mass of PLGA and PDO, and the molar ratio of LA structural unit to GA structural unit in PLGA is 1:1;

[0084] The second nanofibrous layer includes polylactic-co-glycolic acid (PLGA) (molecular weight: 40,000), polyglycolic acid (PGA) (intrinsic viscosity: 2.5-4.0dL / g) and doxorubicin, PLGA and PGA The mass ratio is 6:4, doxorubicin accounts for 10% of the total mass of PLGA and PGA, and the molar ratio of LA structural unit to GA structural unit in PLGA is 3:1;

[0085] Described the 3rd nano...

Embodiment 3

[0092] This embodiment provides a drug-loaded nanocomposite fiber membrane system, the drug-loaded nanocomposite fiber membrane system includes a first nanofiber layer, a second nanofiber layer and a third nanofiber layer;

[0093] The first nanofiber layer includes poly(lactic-co-glycolic acid) (PLGA) (molecular weight is 40000), polydioxanone (PDO) (intrinsic viscosity is 2.4-4.8dL / g) and 5-fluorouracil, The mass ratio of PLGA to PDO is 7:3, 5-fluorouracil accounts for 15% of the total mass of PLGA and PDO, and the molar ratio of LA structural unit to GA structural unit in PLGA is 1:1;

[0094] The second nanofibrous layer includes poly(lactic-co-glycolic acid) (PLGA) (molecular weight: 200,000), polyglycolic acid (PGA) (intrinsic viscosity: 8.0-9.0dL / g) and 5-fluorouracil, PLGA and PGA The mass ratio is 7:3, 5-fluorouracil accounts for 10% of the total mass of PLGA and PGA, and the molar ratio of LA structural unit to GA structural unit in PLGA is 3:1;

[0095] The third n...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
viscosity average molecular weightaaaaaaaaaa
viscosity average molecular weightaaaaaaaaaa
viscosity average molecular weightaaaaaaaaaa
Login to view more

Abstract

The present invention relates to a drug-loaded nanocomposite fiber membrane system and its preparation method and application. The drug-loaded nanocomposite fiber membrane system includes a first nanofiber layer, a second nanofiber layer and a third nanofiber layer; the first nanofiber layer A nanofiber layer includes poly(lactic-co-glycolic acid), polydioxanone, and medicine; the second nanofiber layer includes poly(lactic-co-glycolic acid), polyglycolic acid, and medicine; the third nanofiber The fibrous layer includes poly(lactic-co-glycolic acid), polyethylene glycol, and drug. The preparation method is as follows: respectively dissolving and mixing the polymer materials and drugs contained in each nanofiber layer to obtain three mixed solutions; performing electrospinning on the three mixed solutions in sequence to obtain the drug-loaded nanocomposite fiber membrane system . The system is a complete drug sustained release system from 0 days to 2.5 months, which realizes multi-gradient, multi-stage and long-acting drug release.

Description

technical field [0001] The invention belongs to the technical field of fiber membranes, and in particular relates to a drug-loaded nanocomposite fiber membrane system and its preparation method and application. Background technique [0002] There are many risk factors for recurrence after tumor resection. The tumor center can be completely removed by surgical resection. For most cancer sites, due to the functionality of the organ, a large area cannot be removed during resection, which makes the surrounding calcification The resection of the area is not clean, so that the recurrence rate of cancer after surgery is greatly increased. Traditional postoperative adjuvant chemotherapy can eliminate residual tumors and subclinical lesions, but chemotherapy drugs spread throughout the body with blood circulation, which is toxic to healthy organs and tissues and has low drug utilization. The method of targeted chemotherapy is particularly important. [0003] How to specifically des...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/70A61K47/10A61K47/34A61K31/337A61K31/513A61K31/704A61K33/243A61P35/00D01D5/00D04H1/728
CPCA61K9/70A61K31/337A61K31/513A61K31/704A61K33/243A61K47/10A61K47/34A61P35/00D04H1/728A61K47/32D01F1/10D01F6/84D01D5/0038D01D5/00D04H3/011B32B2262/0276B32B2307/716B32B2535/00B32B2250/20B32B5/02B32B5/26B32B2262/02B32B2250/03A61K9/7007D01D5/0007
Inventor 韩志超许杉杉伍家恩王岚
Owner SHENZHEN GUANGYUAN BIOMATERIAL CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap